Dare Bioscience (DARE) Trading Down 0%
Dare Bioscience Inc (NASDAQ:DARE)’s share price fell 0% during trading on Wednesday . The stock traded as low as $1.65 and last traded at $1.68. 3,178,600 shares were traded during trading, an increase of 644% from the average session volume of 427,341 shares. The stock had previously closed at $1.68.
Separately, ValuEngine upgraded shares of Dare Bioscience from a “strong sell” rating to a “sell” rating in a research report on Saturday, December 9th.
Dare Bioscience Company Profile
Dare Bioscience, Inc, formerly Cerulean Pharma Inc, is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse.
Receive News & Ratings for Dare Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dare Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.